Dec 06,2022

Global Interventional Oncology Market Report 2022 to 2028 - Featuring Teleflex, Medtronic, Terumo and Johnson & Johnson Among Others

The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period. Interventional oncology (IO) is an emerging subspecialty that emphasizes on using image-guided processes (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care.

View Analyst & Ambassador Comments
Go to original news
Dec 06,2022

Cancer Diagnostics Global Market to Reach $293.5 Billion by 2030 at a CAGR of 6.89%

The "Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), by Technology, by Screening Type, by Application, by End-user, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

View Analyst & Ambassador Comments
Go to original news
Dec 07,2022

OncoHealth Appoints Susan Hoang as Chief Data & Analytics Officer

OncoHealth®, a leading digital health company dedicated to oncology, today announced the appointment of Susan Hoang, PharmD, as the company's Chief Data & Analytics Officer. An innovative and results-oriented healthcare data and analytics leader with experience developing and launching revolutionary value-based care programs, Hoang will be responsible for building out and maintaining OncoHealth's ongoing organizational analytics and data strategy.

View Analyst & Ambassador Comments
Go to original news
Dec 07,2022

TerSera® to sponsor "NET Cancer Health Storylines" digital platform to support patients suffering from Carcinoid Syndrome Diarrhea

TerSera Therapeutics announced today a new sponsorship with the Carcinoid Cancer Foundation (CCF) and Alira Health to expand and optimize a holistic patient journey digital platform for patients with Neuroendocrine Tumors (NET) and Carcinoid Syndrome. Alira Health and the Carcinoid Cancer Foundation have collaborated since 2015 to build "NET Cancer Health Storylines," a customized version of the Health Storylines™ app that makes it easy for patients to record their symptoms, nutritional concerns, moods, medication and more.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 08,2022

Quantum Health Announces New Clinical Advisory Board to Expand Existing Cancer Care Member Journey Experience and Support

Quantum Health announced today the formation of their new clinical advisory board. Quantum Health will expand its ability to support members through their entire cancer care journey, including finding high-quality cancer care at leading cancer centers, accessing top-rated oncology providers and researchers, identifying clinical trial options in their geographic location, and financial impact and behavioral health support.

View Analyst & Ambassador Comments
Go to original news
Dec 08,2022

CDC Foundation Launches Tools for Cancer Patients and Healthcare Providers to Improve Overall Health Outcomes

The CDC Foundation today announced a suite of new resources and tools to improve cancer outcomes as part of its Empowered Health program. These new resources include the Empowered Health Academy, with content tailored to both patients and providers, and a peer support community, including a group directory. Empowered Health is an evidence-based program designed to empower individuals to take an active role in their health, and to help patients and providers strengthen their relationships, improve their conversations, and make important medical decisions together.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Dec 08,2022

Artificial Intelligence (AI)-Based Digital Pathology Solutions Market to Record Rapid Growth with CAGR of 7.67% by 2030

According to the latest research by InsightAce Analytic, the global AI-Based Digital Pathology solutions market is expected to grow with a CAGR of 7.67% during the forecast period of 2022-2030. The prominent market players includes PathAI, Paige.AI, Akoya Biosciences, and many others.

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Dec 09,2022

Sarah Cannon Research Institute to Present Latest Research Insights at the 2022 ASH Annual Meeting & Exposition

Sarah Cannon Research Institute (SCRI), US Oncology Research (USOR), and Ontada announced that collectively more than 65 affiliated abstracts and presentations will be highlighted at the American Society of Hematology (ASH) Annual Meeting & Exposition from Dec. 10-13.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Dec 09,2022

Global Molecular Oncology Diagnostics Market to Reach $12.13 Billion by 2032

According to this study, the market for global molecular oncology diagnostics was valued at $3.62 billion in 2021 and is projected to reach $12.13 billion by 2032.

View Analyst & Ambassador Comments
Go to original news
Dec 12,2022

Machine learning in radiology: the new frontier in interstitial lung diseases

Machine-learning algorithms can identify ILD in at-risk populations, predict the extent of lung fibrosis, correlate radiological abnormalities with lung function decline, and be used as endpoints in treatment trials, exemplifying how this technology can be used in care for people with ILD. The purpose of this Review is to describe the clinical and research gaps in the diagnosis and prognosis of ILD, and how machine learning can be applied to image biomarker research to close these gaps.

CLINICAL STUDY

#ai/software

#ml

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY